Literature DB >> 21321573

Imaging: standardizing the use of functional MRI in prostate cancer.

Nandita M deSouza, Evis Sala.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21321573     DOI： 10.1038/nrurol.2011.12

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  11 in total

1.  Development and aftercare of clinical guidelines: the balance between rigor and pragmatism.

Authors:  G P Browman
Journal:  JAMA       Date:  2001-09-26       Impact factor: 56.272

Review 2.  Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer.

Authors:  Chan Kyo Kim; Byung Kwan Park; Bohyun Kim
Journal:  AJR Am J Roentgenol       Date:  2010-06       Impact factor: 3.959

3.  A method for pharmacokinetic modelling of dynamic contrast enhanced MRI studies of rapidly enhancing lesions acquired in a clinical setting.

Authors:  Aleksandra Radjenovic; John P Ridgway; Michael A Smith
Journal:  Phys Med Biol       Date:  2006-04-19       Impact factor: 3.609

4.  Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging.

Authors:  Nicolas Barry Delongchamps; Mathieu Rouanne; Thierry Flam; Frédéric Beuvon; Mathieu Liberatore; Marc Zerbib; François Cornud
Journal:  BJU Int       Date:  2010-11-02       Impact factor: 5.588

Review 5.  Dynamic contrast-enhanced magnetic resonance imaging in the evaluation of the prostate.

Authors:  David Bonekamp; Katarzyna J Macura
Journal:  Top Magn Reson Imaging       Date:  2008-12

6.  Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance.

Authors:  V A Morgan; S F Riches; K Thomas; N Vanas; C Parker; S Giles; N M Desouza
Journal:  Br J Radiol       Date:  2011-01       Impact factor: 3.039

7.  MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.

Authors:  Sophie F Riches; Geoffrey S Payne; Veronica A Morgan; Samir Sandhu; Cyril Fisher; Michael Germuska; David J Collins; Alan Thompson; Nandita M deSouza
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

8.  Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection.

Authors:  V A Morgan; S Kyriazi; S E Ashley; N M DeSouza
Journal:  Acta Radiol       Date:  2007-07       Impact factor: 1.990

Review 9.  Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer.

Authors:  Renata Huzjan; Evis Sala; Hedvig Hricak
Journal:  Nat Clin Pract Urol       Date:  2005-09

10.  Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting.

Authors:  Louise Dickinson; Hashim U Ahmed; Clare Allen; Jelle O Barentsz; Brendan Carey; Jurgen J Futterer; Stijn W Heijmink; Peter J Hoskin; Alex Kirkham; Anwar R Padhani; Raj Persad; Philippe Puech; Shonit Punwani; Aslam S Sohaib; Bertrand Tombal; Arnauld Villers; Jan van der Meulen; Mark Emberton
Journal:  Eur Urol       Date:  2010-12-21       Impact factor: 20.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.